about
Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapyImproving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onsetAttenuated psychosis syndrome: benefits of explicit recognition.The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.Values and DSM-5: looking at the debate on attenuated psychosis syndrome.Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis predictionA Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups.Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPSPrediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome.Understanding auditory verbal hallucinations: a systematic review of current evidence.Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.Improving outcomes of first-episode psychosis: an overview.Diagnostic Concepts in the Context of Clinical High Risk/Attenuated Psychosis Syndrome.Early intervention: how early and with what?Diagnostic Categories: Provisional, Not Otherwise Classified, or Place-holder?Getting Better Acquainted with Auditory Voice Hallucinations (AVHs): A Need for Clinical and Social Change.Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study.Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.Interpersonal sensitivity and persistent attenuated psychotic symptoms in adolescence.Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.Psychosis risk screening: Validation of the youth psychosis at-risk questionnaire - brief in a community-derived sample of adolescents.Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis.Beyond the "at risk mental state" concept: transitioning to transdiagnostic psychiatry.Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study
P2860
Q28078158-9834A45E-6769-444B-A4BC-21D9216BD9CCQ31122156-672F6E89-8FFC-4B9F-BEEA-9FD75DF5D92EQ34484906-30C72CCE-5763-43FD-A76F-6A1980738A66Q35214833-CEC2E36C-C659-4A9B-809E-09168D9C81C3Q35382798-5695AABF-2FCD-44A2-A67C-F0F99D5269C4Q35899497-D5D22F42-CBF0-4D90-9CE0-65457B66E793Q35950862-6CB64BD6-D63E-4F7F-BEF9-032712173BA3Q36118724-27DE5491-6CBA-4A4E-9B7C-A4981CAEB925Q36148525-0ECA7F76-6AC5-4EBE-A616-A2BB977D4075Q36995932-B56F5F43-A2F4-4CE6-9D67-FA4E022F87CCQ37307208-68433120-B0F1-4E40-87C6-CA70890AB3AFQ38260578-2096352C-3AF5-47DE-8524-BAD394B641F2Q38667771-343B6235-392B-4C19-A0F4-AF89280D0C91Q38756852-E856912D-39B9-4770-A7F2-FACC5DCB434AQ38929213-5E71ED8A-20D9-4308-A9C5-79F5823DBC4DQ41658737-883CBB5F-B7A1-4DAF-A2EF-564FAB526A71Q42525529-FAFC8646-7D06-4DDC-8B54-806E0976BEBBQ42635604-478F0D44-BF05-4320-9502-D130FCFC20B3Q42650193-B68B2C83-5B7C-472A-94B1-FAB3F3F56090Q47149514-2AC1EFF3-EE2F-4089-883D-ADB6E4CD8324Q47297974-7310FAE1-5882-4458-A0B9-E0E9A31AE371Q47578112-B364A430-1CAF-4E54-9FD2-D72BE139BA3BQ47596285-95FC9E8D-3357-47E0-9CEA-76537BE03CBEQ47620192-C6C18225-FC72-486E-81E6-4D19E39B87C0Q47719258-EE341D09-2D75-4A27-861C-DDD2F12DFB73Q47896893-BD60953C-4A31-410F-A5D4-B0803960D16FQ50596157-2F664FFB-2F90-4E89-BF04-D206104F525DQ55278928-C6C27CA7-1806-4656-BF19-554CFF0A65F7Q55397391-C53B320F-8197-4543-9FD9-ED622F6D5B90Q57519639-5F7DF438-64ED-4F23-AB1B-F86DB5DF2E2E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Attenuated psychosis syndrome: ready for DSM-5.1?
@ast
Attenuated psychosis syndrome: ready for DSM-5.1?
@en
Attenuated psychosis syndrome: ready for DSM-5.1?
@nl
type
label
Attenuated psychosis syndrome: ready for DSM-5.1?
@ast
Attenuated psychosis syndrome: ready for DSM-5.1?
@en
Attenuated psychosis syndrome: ready for DSM-5.1?
@nl
prefLabel
Attenuated psychosis syndrome: ready for DSM-5.1?
@ast
Attenuated psychosis syndrome: ready for DSM-5.1?
@en
Attenuated psychosis syndrome: ready for DSM-5.1?
@nl
P1476
Attenuated psychosis syndrome: ready for DSM-5.1?
@en
P2093
W T Carpenter
P304
P356
10.1146/ANNUREV-CLINPSY-032813-153645
P577
2014-01-17T00:00:00Z